UA98492U - A method of treating transient ischemic attack cardioembolic genesis - Google Patents
A method of treating transient ischemic attack cardioembolic genesisInfo
- Publication number
- UA98492U UA98492U UAU201412975U UAU201412975U UA98492U UA 98492 U UA98492 U UA 98492U UA U201412975 U UAU201412975 U UA U201412975U UA U201412975 U UAU201412975 U UA U201412975U UA 98492 U UA98492 U UA 98492U
- Authority
- UA
- Ukraine
- Prior art keywords
- cardioembolic
- transient ischemic
- ischemic attack
- days
- genesis
- Prior art date
Links
- 208000032109 Transient ischaemic attack Diseases 0.000 title abstract 3
- 230000009426 cardioembolic effect Effects 0.000 title abstract 3
- 201000010875 transient cerebral ischemia Diseases 0.000 title abstract 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 abstract 2
- 229960005080 warfarin Drugs 0.000 abstract 2
- 235000019766 L-Lysine Nutrition 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- 239000003416 antiarrhythmic agent Substances 0.000 abstract 1
- 230000010100 anticoagulation Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000003709 heart valve Anatomy 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A method of treating transient ischemic attack cardioembolic genesis includes the use of drugs. Determine cardioembolic pathogenic subtype of transient ischemic attack and prescribed antiarrhythmic drugs in a dose of 100 mg orally under the control of heart rate, warfarin to achieve an INR of 2.5 (2-3) in patients with artificial heart valves, anticoagulation with warfarin with a target INR of 3 (2,5-3 5) tserakson 1000 mg per 200 ml of physiological sodium chloride solution one time a day intravenously for 5-7 days, followed by 500 mg intramuscularly 7-10 days, L-lysine 10 mL aescinat intravenously 3-7 days.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201412975U UA98492U (en) | 2014-12-04 | 2014-12-04 | A method of treating transient ischemic attack cardioembolic genesis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201412975U UA98492U (en) | 2014-12-04 | 2014-12-04 | A method of treating transient ischemic attack cardioembolic genesis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA98492U true UA98492U (en) | 2015-04-27 |
Family
ID=53502206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201412975U UA98492U (en) | 2014-12-04 | 2014-12-04 | A method of treating transient ischemic attack cardioembolic genesis |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA98492U (en) |
-
2014
- 2014-12-04 UA UAU201412975U patent/UA98492U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY189601A (en) | Treatment of beta-thalassemia using actrii ligand traps | |
| MX2019006207A (en) | Polymorphic form of sepiapterin. | |
| PE20190338A1 (en) | METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL | |
| BR112017014361A2 (en) | methods for perfecting cell therapy | |
| MX381440B (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ULCERATIVE COLITIS. | |
| MX2023005014A (en) | Methods of treating chronic inflammatory diseases. | |
| AU2016206832A8 (en) | Non-invasive systems and methods for treatment of a host carrying a virus with photoactivatable drugs | |
| MD20180049A2 (en) | Pharmaceutical composition | |
| UA98492U (en) | A method of treating transient ischemic attack cardioembolic genesis | |
| RU2014106575A (en) | METHOD FOR PREVENTION OF BLEEDING WITH MYOMECTOMY | |
| RU2016102793A (en) | METHOD FOR ACTIVATING BASIC EXCHANGE IN THE EARLY POST-OPERATIVE PERIOD | |
| SG10201809418VA (en) | New administration routes of insulin, insulin analogs or derivatives of insulin | |
| UA98564U (en) | A method of treating transient ischemic attack atherothrombotic genesis | |
| RU2012115039A (en) | METHOD FOR TREATING CHRONIC ENDOMETRITIS | |
| UA99513U (en) | Method for treatment of transitory ischemic attack of lacunar genesis | |
| UA98493U (en) | A method of treating transient ischemic attack | |
| UA116484U (en) | METHOD OF TREATMENT OF HYPERTENSION WITH METABOLIC SYNDROME | |
| UA94167U (en) | Method for improving the treatment of thyrotoxic cardiomyopathy | |
| UA104584U (en) | Method for the treatment of acute ischemic stroke | |
| UA108523U (en) | METHOD OF TREATMENT OF PATIENTS WITH EARLY AGAINST POSTINCULAR Dementia | |
| UA105536U (en) | Method for treatment of diastolic heart dysfunction in patients with type 2 diabetes following non-q-myocardial infarction | |
| UA90503U (en) | Method for treating chronic heart failure | |
| UA83410U (en) | Method for treatment of patients with chronic pancreatitis with ischemic heart disease at congestive heart failure | |
| RU2014142874A (en) | A method of treating a hangover syndrome in persons not related to patients with alcoholism | |
| RU2012131719A (en) | METHOD FOR TREATING EXPERIMENTAL PANCREONECROSIS |